Center for Clinical Studies

Institution (Nonprofit)

Homepage ROR

Also Known As

Center for Clinical Studies

1.5K

Publications

50.7K

Citations

Authors

473

Concepts

About

Center for Clinical Studies is a nonprofit institution in Houston, United States known for medicine, health sciences, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	15	45	2.9K
2	Education	8	18	399
3	Engineering	7	10	295
4	Arts	3	3	153
5	Business	1	1	20

Center for Clinical Studies

1.5K

Publications

50.7K

Citations

Page 1

	Year	Citations
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials Richard G. Langley, Boni E. Elewski, Mark Lebwohl, New England Journal of Medicine	2014	1.9K
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms Philipp Harter, Jalid Sehouli, Domenica Lorusso, New England Journal of Medicine	2019	571
Off-Pump versus On-Pump Coronary-Artery Bypass Grafting in Elderly Patients Anno Diegeler, Jochen Börgermann, Utz Kappert, New England Journal of Medicine	2013	504
Physicians' Experience with the Acquired Immunodeficiency Syndrome as a Factor in Patients' Survival Mari M. Kitahata, Thomas D. Koepsell, Richard A. Deyo, New England Journal of Medicine	1996	462
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure Timothy P. Hughes, Michael J. Mauro, Jörge E. Cortes, New England Journal of Medicine	2019	449
Severe Mental Illness and Risk of Cardiovascular Disease John W. Newcomer, Charles H. Hennekens JAMA Psychiatric DisordersOtorhinolaryngologySurgeryMental HealthMedical Diagnosis	2007	431
Antipsychotic medications: metabolic and cardiovascular risk. John W. Newcomer PubMed Metabolic DisorderCardiometabolic RiskPsychotropic MedicationPsychopharmacologyPharmacotherapy	2007	418
An International Comparison of Back Surgery Rates Daniel C. Cherkin, Richard A. Deyo, John D. Loeser, Spine	1994	415
Noncancer Disease Incidence in Atomic Bomb Survivors, 1958–1998 Michiko Yamada, F. Lennie Wong, Saeko Fujiwara, Radiation Research Noncancer Disease IncidenceOccupational Health SciencesRadiation EffectClinical EpidemiologyNoncancer Diseases	2004	336
The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy Lars Hanker, Sibylle Loibl, Nicole Burchardi, Annals of Oncology MedicinePrimary Taxane/platinum-based TherapyGynecologyLine TherapyRelapsed Ovarian Cancer	2012	333

Page 1